- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 453/02 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Patent holdings for IPC class C07D 453/02
Total number of patents in this class: 632
10-year publication summary
|
58
|
36
|
56
|
38
|
39
|
23
|
23
|
34
|
20
|
9
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chiesi Farmaceutici S.p.A. | 965 |
40 |
| Genzyme Corporation | 1262 |
16 |
| Corsair Pharma, Inc. | 37 |
14 |
| Astellas Pharma Inc. | 1087 |
13 |
| Renexxion, LLC | 14 |
12 |
| Glaxo Group Limited | 4063 |
11 |
| Novartis AG | 10744 |
11 |
| Bristol-myers Squibb Company | 4880 |
10 |
| Vertex Pharmaceuticals Incorporated | 1600 |
10 |
| Merck Patent GmbH | 5815 |
9 |
| Beijing Showby Pharmaceutical Co., Ltd. | 15 |
9 |
| AstraZeneca AB | 2892 |
8 |
| Array BioPharma Inc. | 498 |
8 |
| Obschestvo S Ogranichennoi Otvetstvennostiyu "pharmenterprises" | 31 |
8 |
| SK Biopharmaceuticals Co., Ltd. | 262 |
8 |
| Boehringer Ingelheim International GmbH | 4642 |
7 |
| Almirall, S.A. | 494 |
7 |
| Hovione Scientia Limited | 133 |
7 |
| Mitsubishi Tanabe Pharma Corporation | 582 |
7 |
| XENIOPRO GmbH | 15 |
7 |
| Other owners | 410 |